Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers

JAMA Neurology - Tập 74 Số 3 - Trang 339 - 2017
Hussein N. Yassine1, Meredith N. Braskie2, Wendy J. Mack3, Katherine Castor4, Alfred N. Fonteh4, Lon S. Schneider5,6, Michael G. Harrington4, Elizabeth Fisher5
1Division of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles
2Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey
3Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
4Department of Neurosciences, Huntington Medical Research Institutes, Pasadena, California
5Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles
6Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles6Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA Neurology

Tập 74 Số 3

339

Thông tin tác giả